0001209191-14-059943.txt : 20140926
0001209191-14-059943.hdr.sgml : 20140926
20140926160825
ACCESSION NUMBER: 0001209191-14-059943
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140924
FILED AS OF DATE: 20140926
DATE AS OF CHANGE: 20140926
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141124158
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-09-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2014-09-24
4
M
0
5200
11.27
A
344095
D
Common Stock
2014-09-24
4
S
0
600
106.25
D
343495
D
Common Stock
2014-09-24
4
S
0
1200
107.39
D
342295
D
Common Stock
2014-09-24
4
S
0
500
108.57
D
341795
D
Common Stock
2014-09-24
4
S
0
100
109.04
D
341695
D
Common Stock
2014-09-24
4
S
0
1000
109.71
D
340695
D
Common Stock
2014-09-24
4
S
0
1000
111.04
D
339695
D
Common Stock
2014-09-24
4
S
0
800
111.69
D
338895
D
Common Stock
13286
I
401(k)
Common Stock
300000
I
Common Stock held in trust
Stock Option (right to buy)
11.27
2014-09-24
4
M
0
5200
0.00
D
2014-10-06
Common Stock
5200
5700
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $106.25 (range $105.87 to $106.57).
Open market sales reported on this line occurred at a weighted average price of $107.39 (range $106.94 to $107.90).
Open market sales reported on this line occurred at a weighted average price of $108.57 (range $108.04 to $109.01).
Open market sales reported on this line occurred at a weighted average price of $109.71 (range $109.15 to $110.04).
Open market sales reported on this line occurred at a weighted average price of $111.04 (range $110.33 to $111.23).
Open market sales reported on this line occurred at a weighted average price of $111.69 (range $111.40 to $111.93).
Common stock held in grantor retained annuity trusts.
Fully vested.
Kenneth L. Horton, Attorney-In-Fact
2014-09-26